CVE-2021-31562Fresenius Kabi Agilia Connect Infusion System use of a broken or risky cryptographic algorithm
Updated under an hour ago ()
Does this affect you?
It affects Fresenius Kabi Agilia Link+ and 6 other products. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.49%, higher than 42% of scored CVEs.
Do this next
Free account, 1 product
The SSL/TLS configuration of Fresenius Kabi Agilia Link + version 3.0 has serious deficiencies that may allow an attacker to compromise SSL/TLS sessions in different ways. An attacker may be able to eavesdrop on transferred data, manipulate data allegedly secured by SSL/TLS, and impersonate an entity to gain access to sensitive information.
- CVSS
- 6.5 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
- Weakness (CWE)
- CWE-327
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.49% (percentile 42)
- Assigned by
- icscert
- NVD analysis
- Modified
- Record last updated
- Apr 16, 2025
- First seen by InfoSec Signals
- Oct 12, 2026
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.